CPMV
MOSAIC IMMUNOENGINEERINGstockOTC
EODNov 17, 2026
0.076USD+26.667%(+0.016)108
CPMV Financials
In Q2 FY 2026 (ended ), MOSAIC IMMUNOENGINEERING (CPMV) reported net income of −$177.5K, operating cash flow of −$46, and assets of $3.28K (filed ).
Loading financial flows…